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heme oxygenase-1 (HO-1) pathway, which is able to counteract cellular
stress in vitro and in vivo. The present study was aimed at identifying a
possible regulatory effect of HO-1 on HMGB1 in OA synoviocytes.
Methods: Synovial tissue samples were obtained from 15 OA patients
undergoing total knee joint replacement. Synoviocytes (ﬁbroblasts and
macrophage-like) were obtained by digestion with collagenase IA, cul-
tured in third passage and treated with interleukin-1b (Il-1b, 100U/ml) for
24 h. HO-1 was induced by treatment with cobalt protoporphyrin IX (CoPP,
10mM). Matrix metalloproteinase (MMP) activity was determined by ﬂuo-
rometric procedures and HMGB1 release by ELISA. Protein expression
was studied by Western blot.
Results: Basal expression of HMGB1 protein was reduced by HO-1
induction in OA synoviocytes. In addition, HMGB1 release into the
medium was signiﬁcantly decreased. Stimulation of synoviocytes with
Il-1b resulted in an enhancement of HMGB1 cellular content and release.
Our results indicate that both processes are down-regulated by HO-1
overexpression. In addition, HO-1 reduced RAGE expression in these
cells. The effects of HO-1 induction were prevented when synoviocytes
were transfected with a siRNA speciﬁc for human HO-1. In cells without
HO-1 induction, HO-1 gene silencing resulted in the up-regulation of
HMGB1 and RAGE. Regulation of HMGB1 by HO-1 was accompanied
by the inhibition of MMP activity in synoviocytes stimulated with Il-1b.
Conclusions: Our data provide evidence that HO-1 can regulate HMGB1
in OA synoviocytes. Overall, HO-1 signaling appears to be an appropriate
target for the development of novel therapies affecting articular disorders.
436 EFFECT OF EPIGALLOCATECHIN GALLATE ON THE
INFLAMMATORY RESPONSE OF Il-1-EXPOSED SYNOVIAL
FIBROBLASTS
P. Sfriso, F. Oliviero, A. Scanu, R. Luisetto, U. Fiocco, L. Punzi.
University of Padova, Padova, ITALY
Purpose: Inﬂammation is increasingly recognized as contributing to the
symptoms and progression of osteoarthritis (OA). Synovitis is a factor
that likely contributes to dysregulation of chondrocyte function, favoring
an imbalance between the catabolic and anabolic activities of the chon-
drocyte in remodeling the cartilage. In recent years, signiﬁcant interest
has emerged in the beneﬁcial health effects attributed to the green tea
polyphenols. Polyphenols in green tea are potent antioxidants, with the
majority of the beneﬁcial effects elicited by epigallocatechin-3-gallate
(EGCG), one of the main constituent of green tea.
Among several inﬂammatory mediators, interleukin-1beta (Il-1) plays a
pivotal role in the pathophysiology of OA. We therefore assessed the
effect of EGCG on the production of interleukin-8 (Il-8) and interleukin-1
receptor antagonist (Il-1ra) in primary cultured synovial ﬁbroblasts stimu-
lated with Il-1.
Methods: Human synovial ﬁbroblasts were stimulated for 24 hours with
Il-1 (10 ng/ml) in the presence or absence of EGCG (0.1−5 mM).
The levels of Il-8 and Il-1ra were measured in cell supernatants by
enzyme-linked immunoassay methods. The lack of cell cytotoxicity of
EGCG was ensured using the colorimetric MTT assay.
Results: Treatment of synovial ﬁbroblasts with EGCG resulted in a
marked inhibition of Il-1-induced Il-8 production. EGCG also increased in
a dose-dependent manner the release of Il-1ra by stimulated ﬁbroblasts.
Conclusions: The present study shows that EGCG, at dose comparable
with plasma concentration achieved by the consumption of two cups of
tea, suppressed the inﬂammatory response of Il-1-exposed synovial ﬁ-
broblasts. The suppressive effect of EGCG may be due to the interference
with inﬂammatory signal transduction pathway or may be related to the
inhibition of the release and the accumulation of reactive oxygen species.
Our ﬁndings suggest that EGCG may be of potential therapeutic value in
the treatment of OA.
437 EFFECT OF EPIGALLOCATECHIN GALLATE ON CALCIUM
CRYSTAL-INDUCED CHEMOTACTIC FACTORS
F. Oliviero, P. Sfriso, A. Scanu, M. Miorin, U. Fiocco, C. Sales,
P. Spinella, L. Punzi. University of Padova, Padova, ITALY
Purpose: Although osteoarthritis (OA) is deﬁned as a cartilage disease,
synovitis involving mononuclear cell inﬁltration and overexpression of
proinﬂammatory mediators is common in early and late OA. Calcium
crystals deposition is a factor that likely contributes to synovial membrane
inﬂammation.
Polyphenols in green tea are potent antioxidants, with the majority of the
beneﬁcial effects elicited by epigallocatechin-3-gallate (EGCG), one of
the main constituent of green tea. The aim of our study was to evaluate if
EGCG may inﬂuence some inﬂammatory aspects of OA. To this aim we
studied the effect of EGCG on chemotactic factors released by human
ﬁbroblasts stimulated with calcium crystals, regular features of the most
severe forms of OA.
Methods: Human synovial ﬁbroblasts were stimulated with pyrophos-
phate dihydrate (CPPD) and basic calcium phosphate (BCP) crystals
(0.01−0.1mg/ml) in the presence or absence of EGCG (0.1−5mM).
Il-1beta (10 ng/ml) was used as a positive control.
CPPD and BCP crystals were synthesized by the methods of Cheng
and McCarthy respectively. The levels of MCP-1 were measured in cell
supernatants by enzyme-linked immunoassay methods. The chemotactic
effect of culture supernatants was evaluated on chemotaxis chamber by
the migration of fresh-isolated mononuclear blood cells. The lack of cell
cytotoxicity of both EGCG and calcium crystals was ensured using the
colorimetric MTT assay.
Results: EGCG inhibited MCP-1 release by stimulated ﬁbroblasts in a
dose-dependent manner. Supernatants of crystals-stimulated cells loose
their ability to induce mononuclear cell migration when EGCG was added
in the medium. EGCG inhibited both MCP-1 release and supernatants
chemotactic activity of Il-1beta stimulated culture in a dose-dependent
manner.
Conclusions: The present study shows that EGCG, at dose comparable
with plasma concentration achieved by the consumption of two cups
of tea, modify the inﬂammatory response of calcium crystal-exposed
synovial ﬁbroblasts. EGCG may interfere with inﬂammatory signal trans-
duction pathway and may also inhibits the cellular generation, the release
and the accumulation of reactive oxygen species. Our results suggest
that EGCG might represents a good candidate for the prevention and
treatment of OA.
438 MODULATION OF THE INFLAMMATORY AND CATABOLIC
RESPONSE BY PROSTAGLANDIN E2 (PGE2) IS PARTIALLY
DEPENDENT ON THE INDUCTION OF DUAL SPECIFICITY
PHOSPHATASE 1 (DUSP-1) IN VITRO AND IN VIVO
Q. He, B. Zhai, A. Mancini, J.A. Di Battista. McGill University, Montreal,
QC, CANADA
Purpose: Prostaglandin E2 (PGE2) is an eicosanoid with pleiotropic
properties that binds G-protein coupled receptors, effecting changes in
cell signalling through activation of protein kinases and phosphatases. We
examined PGE2-dependent control of the dual speciﬁcity phosphatase-1
(DUSP-1) in arthritis-affected human synovial ﬁbroblasts (HSF) in culture
and in the dorsal air-pouch mouse model of synovial inﬂammation in vivo.
Methods:
• Cultured human synovial ﬁbroblasts (HSF) were obtained by sequential
enzymic digestion from osteoarthritis-affected synovial membranes.
• Western and Northern blot analyses were used to measure protein,
phosphorylated protein and mRNA expression, respectively.
• Transient transfection assays were employed to express activated sig-
naling molecules, shRNA constructs, and to analyze reporter luciferase
activity.
• Wild type and DUSP-1 null mice were used in the dorsal air pouch
studies. Analytes were measured by ELISA and RT-PCR. Cell inﬁltra-
tion measurements were assessed by ﬂow cytometry.
• Statistical analyses included Student’s T-test and ANOVA
Results: PGE2 induced a robust (7 fold) and rapid (10min) increase in
DUSP-1 mRNA in cultured HSF, reaching a zenith at 30−60min followed
by decay to control levels. A late phase of DUSP-1 mRNA expression was
observed after 4 h and continued for another 20 h. In transient transfection
assays using a DUSP-1 promoter-luciferase reporter construct or a lu-
ciferase reporter construct harbouring the DUSP-1 mRNA 3′-UTR region
fused 3′ prime, PGE2 induced a modest (1.38) increase in promoter
(transcriptional) activity while also stabilizing luciferase-DUSP-1 3′UTR
mRNA chimeric transcripts (2.6 fold; post-transcriptional regulation). With
respect to DUSP-1 protein, PGE2 induced a similar bi-phasic pattern as
observed with DUSP-1 mRNA, appearing within 20−30min, a plateau at
60min, with protein levels declining to near control levels. A second phase
of protein expression was observed from 4h and DUSP-1 protein was
still detectable after 24 h. In terms of measuring DUSP-1 phosphatase
activity, PGE2 abrogated rhIl-1b induced phosphorylation of T183/Y185
of SAPK/JNK, a response abolished by knock down of DUSP-1 through
targeting by over expression with either a shRNA expression construct or
the DUSP-1 inhibitor sanquinarine sulfate. Using speciﬁc PGE2 receptor
(EP) agonists and antagonists, we observed that the PGE2-dependent
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induction of DUSP-1 gene expression was mediated by EP2/EP4 re-
ceptors coupled to both the protein kinase A and p38 MAP kinase
pathways. In the dorsal air-pouch mouse model of synovial inﬂammation,
LPS-treatments provoked air pouch edema and signiﬁcant leukocyte
inﬁltration (predominantly neutrophils, CDw17 and monocytes, CD11c)
after 6−24 h, with concomitant increases in TNF-a, Il-1b, MIP-1a, MMP-8,
MMP-9, and MMP-13 levels in the exudates. Pre-treatment (30min) with
1mmol/L of PGE2 or PGE2 mimetics like forskolin/rolipram reduced LPS-
induced leukocyte inﬁltration by 42±5% (mean±SD) while TNF-a, MIP-
1a, MMP-9, and MMP-13 expression levels fell by 67 to 91% on average.
PGE2-dependent suppression of induced leukocyte inﬁltration and MMP-
9/TNF-a expression were abrogated in DUSP-1 null (−/−) mice.
Conclusions: We conclude that PGE2-dependent modulation of molec-
ular and cellular components of the inﬂammatory/proliferative/catabolic
response is mediated, at least in part, by DUSP-1. DUSP-1 may be
a promising drug target for modulating MAPK-dependent proliferative
responses in arthritis, infectious diseases and cancers.
439 MITOCHONDRIAL DYSFUNCTION ACTIVATES
CYCLOOXYGENASE-2 EXPRESSION IN CULTURED NORMAL
HUMAN SYNOVIOCYTES
N. Valcarcel-Ares, C. Vaamonde-Garcia, R. Riveiro-Naviera, L. Hermida,
B. Lema, F.J. Blanco, M.J. Lopez-Armada. INIBIC-CH Universitario Juan
Canalejo, A Corun˜a, SPAIN
Purpose: Prostaglandin E2 (PGE2) plays a profound role in the
pathogenic processes of rheumatoid arthritis (RA). Recently, it has been
reported that mitochondrial alterations may contribute to the progression
of RA. In this study, we have investigated the relationship between the
dysfunction of mitochondrial respiratory chain (MRC) and the in vitro
expression of COX-2 in cultured normal human synoviocytes.
Methods: Normal human synoviocytes were isolated from knee synovium
obtained from necropsy from 9 adult cadavers (mean age 43 years). Com-
monly used inhibitors of the MRC were employed to induce mitochondrial
dysfunction. Rotenone (1 and 10mg/ml), 3-nitropropionic acid (0.5, 2 and
10mM), Antimycin A (AA: 5, 10 and 20 mg/ml), Sodium azide (2, 10 and
25mM) and Oligomycin (5, 10 and 25mg/ml) were employed as inhibitor
of the complex I, II, III, IV and V of MRC, respectively. Protein and mRNA
COX-2 expression were analyzed by cytometry and real time PCR. PGE2
levels were evaluated by ELISA. As a positive control, COX-2 expression
was induced by Il-1b (1 ng/ml).
Results: Firstly, only the exposure of synoviocytes to AA and oligomycin
signiﬁcantly increased COX-2 protein expression in a time- and dose
dependent manner. The maximal response was observed at 6 h with
a concentration of 20mg/ml AA and 25mg/ml oligomycin (15.4±3.3 and
28.2±10.8 respectively vs. basal 3.6±0.6, n = 6). At the same time, the
positive control, 1 ng/ml Il-1b, induced a COX-2 protein expression of
45±12.6. When the percentage of cells that expressed COX-2 mRNA
was examined by real time RT-PCR the results obtained at 4 h of stim-
ulation were consistent with those of protein expression (30- and 40-
fold increase for 20mg/ml AA and 25mg/ml oligomycin, respectively, vs.
basal 1). The positive control, 1 ng/ml Il-1b, induced a level of COX-2
mRNA expression of 787-fold increase. When the production of PGE2 at
24 h was assessed similar results were obtained (72±23 and 99±38 for
AA and oligomycin, respectively vs. basal 23±1). Secondly, we tested if
mitochondrial dysfunction induced by AA or oligomycin could modulate
the response induced by Il-1b (1 ng/ml) on COX-2 protein expression.
We found that pre-treatment of synoviocytes with either 5 mg/ml AA or
10mg/ml oligomycin for 30 minutes increases signiﬁcantly the expression
of COX-2 induced by Il-1b (1 ng/ml) at protein levels. The values of COX-2
protein expression were 104.7±38.6 for AA + Il-1b and 96.4±24.4 for
oligomycin + Il-1b vs. 45.0±12.6 for Il-1b (n = 6, p< 0.05).
Conclusions: These results showed that the dysfunction of mitochondrial
respiratory activity induces an inﬂammatory response in synoviocytes
contributing to the chronic inﬂammation of synovial tissue in RA and
aging joint. These data may prove valuable for a better understanding
of the participation of mitochondria in the pathogenesis of RA synovium.
440 ELEVATED LEVELS OF INFLAMMATORY MEDIATOR
PROSTAGLANDIN E2 (PGE2) IN EX-VIVO CULTURED
PERIPHERAL BLOOD LEUKOCYTES (PBL) OF
OSTEOARTHRITIS (OA) PATIENTS
M. Attur, S. Krasnokutsky, I. Belitskaya-Levy, M. Dave, J. Patel,
J. Samuels, P. Rosenthal, S.B. Abramson. NYU Hospital for Joint
Diseases, New York, NY, USA
Purpose:OA is a degenerative joint disease causing loss of joint function,
pain and physical disability. The diarthrodial joint’s diseased tissues
(bone, cartilage, synovium) are sites of production of cytokines (e.g., Il-1b,
TNF-a) and inﬂammatory mediators (e.g., prostaglandins, nitric oxide).
We hypothesize that circulating blood cells, exposed to inﬂammatory
mediators as they perfuse the OA joint, may act as sensors reﬂecting OA
disease activity and/or burden. In the current study we explored whether
PBL from OA patients are primed to produce increased inﬂammatory
mediators compared to PBL from healthy controls.
Methods: We recruited 56 patients with knee OA and 8 age-matched
healthy controls.). QRT-PCR was performed using Applied Biosystems.
PGE2 levels were measured by ELISA (Cayman) from stored plasma
samples.
Results: OA patients produced moderately higher levels of PGE2 than
healthy controls in unstimulated plasma at baseline (p = 0.081). However,
when whole blood from both OA and controls was cultured (24 h) ex
vivo (100 and 94 pg/ml respectively), PGE2 in controls did not change,
while levels in OA patients increased 300% over baseline (p< 0.01). The
increased PGE2 production at 24 hr ex vivo suggested that OA PBLs may
be primed or activated in vivo. We therefore examined mRNA (QPCR)
expression of PBL COX-2, Il-1b and TNFa. Each of these transcripts
were elevated in OA patients (p< 0.02) compared to controls. PBL levels
of Il-1b in OA correlated with TNFa levels (r = 0.43, p = 0.003); increased
COX-2 expression correlated weakly with TNFa expression (r = 0.213,
p< 0.0003). When stratifying these inﬂammatory mediator levels in OA
patients by NSAID use, we observed higher levels of both baseline PGE2
(p< 0.04) and Il-1b mRNA (p=0.04) in NSAID users compared with non-
users. Finally, we asked whether evidence of PBL activation correlated
with radiographic ﬁndings. PBL PGE2 production signiﬁcantly correlated
with semi-quantitative subchondral sclerosis scores (r = 0.37, p< 0.013)
and negatively correlated with osteophyte scores (r = −0.268, p< 0.05).
PGE2 levels trended to correlate with increasing KL scores (p = 0.1).
Relative expression levels of Il-1b but not TNFa moderately correlated
(r = 0.263, p< 0.05) with WOMAC pain score and not with any other x-ray
ﬁndings. (p = 0.4).
Conclusions: OA PBL produce higher levels of PGE2 than do age-
matched controls. PGE2 production is associated with increased PBL
expression of mRNA for COX-2, Il-1b and TNF-a. These data indicate that
PBL are activated by exposure to inﬂammatory stimuli as they circulate
through the diseased synovium and bone in patients with OA. We propose
that activated PBL can serve as biomarkers for disease activity in OA
and may predict patients at risk for disease progression. Whether the
activation of PBL confers a risk of endothelial injury and vascular disease
over time merits additional evaluation.
441 COMMON GAMMA-CHAIN CYTOKINES IN PATIENTS WITH
EARLY AND END-STAGE OSTEOARTHRITIS
C.R. Scanzello1, E. Umoh1, T. Miles2, H.G. Potter1, R. Marx1,
S. Rodeo1, S.R. Goldring1, M.K. Crow1. 1Hospital for Special Surgery,
New York, NY, USA, 2Albert Einstein College of Medicine, New York,
NY, USA
Purpose: Innate immune system activation has been implicated in os-
teoarthritis (OA) pathogenesis, but much of what we know about the
synovial inﬂammatory response in this prevalent joint disease is derived
from studies of end-stage patients. In this study, we sought to better
characterize cytokine production in patients with early signs of knee OA,
focusing on the common gamma chain cytokines Il-15 and Il-21, important
mediators linking the innate and adaptive immune response.
Methods: Synovial membrane (SM) and ﬂuid (SF) specimens were col-
lected from patients with degenerative meniscal tears and early cartilage
degeneration undergoing arthroscopic procedures (early OA) and pa-
tients undergoing total knee replacement for end-stage OA. Quantitative
real-time PCR was used to compare expression of SM cytokines and
cell lineage-speciﬁc markers. SF cytokine and matrix-metalloproteinase
(MMP-1 and MMP-3) levels (proteases implicated in cartilage extracellular
matrix remodeling) were quantiﬁed by ELISA. Transcript and protein
levels were compared in early and end-stage specimens, using the
